Venture Initiative

Scientist doing research

Our philosophy

We invest globally in companies who are pursuing innovative, breakthrough science. Our primary goal is to link our expertise with advanced ideas and technologies from emerging companies or academic institutions.

Through the Merz Corporate Venture Capital Initiative, we offer up initial funding in the early stages of development of a company or technology and are committed to further investments in pace with the company’s progress. This could be alone, or in conjunction with other venture capital and investment funds.
In addition to financial backing, we provide extensive experience and a global network that allows our partners to work closely with management teams and fellow investors to create significant value.


Our focus

We are seeking outstanding ideas and promising technologies that are capable of generating a high level of consumer interest.

Although our interest is primarily focused on early stage projects and seed investments, our goal is to maximize the value of our entire portfolio, including the development of promising later stage investments and opportunities across all of Merz’s focus areas

Female Scientist

Our value

We pride ourselves on our long-standing commitment to both innovation and continuity. In line with our strategic interests, we are open to proactive and long-term engagement with our partners, and we hope to provide much more than financial backing.

We seek to directly connect our investments to Merz’ global infrastructure by offering access to relevant experts in our scientific research network and providing commercial insights into global markets.

Our Partners and Investments

Brooklyn Soap Company

The start-up company Brooklyn Soap stands for honest men's care. The idea for Brooklyn Soap was born in Brooklyn, NY, and has its headquarters in Hamburg, Germany. The founder-managed company offers natural care products for every skin type, every hair type and every beard type and is characterized by extremely agile product development and innovation processes. Merz and Brooklyn Soap have in 2020 on a strategic partnership to benefit from the competencies of the other. This partnership led after one and a half years to the full acquisition of Brooklyn Soap by Merz.

Read more

Cytrellis Biosystems

Cytrellis is a clinical stage company that has been developing an entirely new category of medical devices for the aesthetics market. Cytrellis’ key proprietary technology removes excess skin without invasive surgery or scarring. This technology will enable physicians to improve sagging skin associated with aging on the face and other areas of the body, thereby addressing one of the aesthetic industry’s largest unmet needs and most valuable opportunities.

Read more


Teijin (TSE: 3401) is a technology-driven global group offering advanced solutions in the areas of environmental value; safety, security and disaster mitigation; and demographic change and increased health consciousness. Merz and Teijin Limited have entered into a strategic license and co-development agreement for the commercialization of Xeomin® (incobotulinumtoxinA) for Japan.

Read more

Contact Us

If you would like to submit a speculative application or apply for an open position, please make sure
to use only our job portal, which you can find at the following link:
Please note that we cannot consider your application if you send it via any other channel.

Please prove you are human by selecting the Tree.

* mandatory fields

Please note that if you submit information to Merz all materials submitted by electronic or physical communication will be deemed non-confidential. Do not submit any information or other materials that you consider to be confidential or proprietary. While we have no intention to publicly disclose any details of your proposal, we may refer to select experts within or outside the Merz network for evaluation.